Daniel Sillence (Dan J Sillence)

Loop profile Loop profile Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Venues

FEBS letters

Journal of neurochemistry

Journal of psychopharmacology (Oxford, England)

De Montfort University

University of Dundee (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

De Montfort University

United Kingdom

Reader in Cell Biology :: Pharmacy

Education History

University of Dundee

United Kingdom

PHD :: Biochemistry

Publications

Simon Wheeler, Meenakshi Bhardwaj, Victor Kenyon, Maria J Ferraz, Johannes M F G Aerts, Daniel Sillence
Mitochondrial dysfunction in NPC1-deficiency is not rescued by drugs targeting the glucosylceramidase GBA2 and the cholesterol-binding proteins TSPO and StARD1. FEBS letters (2024)
Simon Wheeler, Meenakshi Bhardwaj, Victor Kenyon, Maria J Ferraz, Johannes M F G Aerts, Daniel Sillence
Mitochondrial dysfunction in NPC1-deficiency is not rescued by drugs targeting the glucosylceramidase GBA2 and the cholesterol-binding proteins TSPO and StARD1. FEBS letters 598 (4) (2024)
Simon Wheeler, Meenakshi Bhardwaj, Victor Kenyon, Maria J Ferraz, Johannes M F G Aerts, Daniel Sillence
Mitochondrial dysfunction in NPC1-deficiency is not rescued by drugs targeting the glucosylceramidase GBA2 and the cholesterol-binding proteins TSPO and StARD1. FEBS letters 598 (4) (2024)
Simon Wheeler, Meenakshi Bhardwaj, Victor Kenyon, Maria J Ferraz, Johannes M F G Aerts, Daniel Sillence
Mitochondrial dysfunction in NPC1-deficiency is not rescued by drugs targeting the glucosylceramidase GBA2 and the cholesterol-binding proteins TSPO and StARD1. FEBS letters (2024)
Estabraq Jaddoa, Jinit Masania, Eva Masiero, Tiziana Sgamma, Randolph Arroo, Daniel Sillence, Tyra Zetterström
Effect of antidepressant drugs on the brain sphingolipid system. Journal of psychopharmacology (Oxford, England) 34 (7) (2020)
Simon Wheeler, Daniel Sillence
Niemann-Pick type C disease: cellular pathology and pharmacotherapy. Journal of neurochemistry 153 (6) (2019)

Daniel Sillence.css-eqlu8i{font-size:small;padding-left:4px;} (Dan J Sillence)

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel Sillence (Dan J Sillence)